Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19M Sell
4,452
-10
-0.2% -$2.77K 0.11% 98
2025
Q4
$1.23M Buy
4,462
+249
+6% +$69.8K 0.12% 92
2025
Q3
$1.21M Buy
4,213
+107
+3% +$31.7K 0.12% 88
2025
Q2
$1.36M Buy
4,106
+332
+9% +$107K 0.15% 87
2025
Q1
$1.24M Sell
3,774
-109
-3% -$32.8K 0.16% 75
2024
Q4
$1.07M Buy
3,883
+637
+20% +$203K 0.13% 80
2024
Q3
$1.18M Sell
3,246
-10
-0.3% -$3.44K 0.17% 80
2024
Q2
$1.08M Buy
3,256
+10
+0.3% +$3.45K 0.15% 84
2024
Q1
$1.18M Sell
3,246
-40
-1% -$13.2K 0.17% 80
2023
Q4
$984K Sell
3,286
-10
-0.3% -$2.92K 0.16% 87
2023
Q3
$943K Buy
3,296
+49
+2% +$14K 0.17% 88
2023
Q2
$911K Buy
+3,247
New +$846K 0.16% 89

Other funds holding CI

Nemes Rush Group's CI Position: Q1 2026 in Review

Nemes Rush Group reduced its Cigna (CI) stake by 0.22% in Q1 2026, selling an estimated $2.77K and leaving 4,452 shares worth $1.19M. The position accounts for 0.11% of the portfolio, ranked #98.

Nemes Rush Group first reported a position in CI in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.36M in Q2 2025. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Nemes Rush Group held 4,452 shares of Cigna worth $1.19M as of Q1 2026.
  • Nemes Rush Group sold 10 Cigna shares in Q1 2026, an estimated $2.77K.
  • Cigna made up 0.11% of Nemes Rush Group's portfolio in Q1 2026, its #98 holding.
  • Nemes Rush Group first reported a position in Cigna in Q2 2023 and has held it in 12 quarters since.
  • Nemes Rush Group's Cigna position peaked at $1.36M in Q2 2025.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.